Disease Focus

Your Go to Provider for Disease State Tissue & Biofluids

The surge in research and development activities focused on personalized medicine coincides with the rapidly decreasing cost of human genome mapping and a greater understanding of disease heterogeneity. As a researcher, you struggle with high attrition rate based on lack of clinical efficacy. It is crucial to your studies to utilize ethically collected, well-characterized human specimens and comprehensive tissue-based research services.
Look to BioIVT for expertise in the processes required for the ethical acquisition of biospecimens that cover a wide range of disease states and the protocols needed for the production of reliable data.

We offer:

BioIVT now has a network of over 200 IRB-approved facilities providing access to a diverse array of specimens. Our growing clinical network is made up of physicians, research groups, hospitals, and reference labs that we work closely with to provide tailored specimen collections to meet your research needs.

ASTERAND Human Tissue Specimens

Over 175,000 tissue samples collected in a standard format, banked and available for immediate shipment
Formats: FFPE, frozen, plasma, serum, whole blood and matched sets of donor specimens
Rigorous QC:
- Specimens reviewed by board-certified pathology to confirm diagnosis and specimen quality
- Clinical data review of over 200 data points
- Ethical and regulatory traceability for each case

Biofluid Specimens

Biofluids are available as both banked inventory or custom collection with associated clinical data such as medication, cancer or disease stage, clinical lab values such as cholesterol and liver function, RF value and viral serology. Available matrices include - Whole blood/ Serum / Plasma, Sputum, Synovial fluid, Cerebrospinal fluid (CSF), PAP smears, Bone marrow, Cord blood, Oral swabs/Saliva/Sputum, Tears, Urine, Feces

Customized collections kits:
- Donor specifications, protocols, collection containers and more
Repeat donor collections for longitudinal studies
Access to unique or rare patient populations, including pediatric and pregnant donors
Matched sets from individual donors